According to reports by the Chicago Tribune, Takeda Pharmaceuticals' Uloric drug has received FDA's approval for treatment of gout - a painful joint disease causing inflammation, severe pain, and warmth in affected joints. Earlier, in November, FDA's arthritis advisory committee, I a 12-0 voting, had recommended approval of Uloric for chronic gout.